On the other hand, both studies show that mismatched cord-blood transplants are less apt to spawn acute attacks of
graft-versus-host disease than mismatched marrow is.
Five days after cessation of the iHg injections, both case and control mice were intravenously administered spleen cells from another mouse strain to induce chronic
graft-versus-host disease (GVHD), a well-established murine model of acquired autoimmunity.
Biohybrid's product platform of hybrid antibodies and genetically engineered vectors are agents for the treatment of graft rejection,
graft-versus-host disease, and autoimmune disorders.
